Karlo Perica

Title: The Innovative Contributions of Karlo Perica

Introduction

Karlo Perica is a notable inventor based in Baltimore, MD (US), recognized for his significant contributions to the field of immunotherapy. With a total of 5 patents, he has made strides in developing advanced technologies that enhance the effectiveness of immune responses.

Latest Patents

One of his latest patents is focused on nanoscale artificial antigen presenting cells (aAPC). This innovation provides nano-scale aAPCs that deliver stimulatory signals to lymphocytes, including T-helper lymphocytes, serving as a powerful tool for immunotherapy. Another significant patent involves reagents and methods for identifying, enriching, and expanding antigen-specific T cells. This technology allows for the enrichment and expansion of antigen-specific T cells, including rare precursor cells, in culture. Such advancements provide a platform for more effective immunotherapy through adoptive transfer and enable the personalization of immunotherapy by determining T cell reactivity with a library of candidate peptide antigens.

Career Highlights

Karlo Perica is affiliated with The Johns Hopkins University, where he continues to push the boundaries of research in immunotherapy. His work is characterized by a commitment to improving therapeutic strategies that can lead to better patient outcomes.

Collaborations

Throughout his career, Karlo has collaborated with esteemed colleagues such as Jonathan Schneck and Mathias Oelke. These partnerships have fostered an environment of innovation and have contributed to the advancement of immunological research.

Conclusion

Karlo Perica's contributions to immunotherapy through his patents and research at The Johns Hopkins University highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches that could significantly impact patient care.